The ongoing obesity epidemic represents a global public health crisis that contributes to
poor health outcomes, reduced quality of life, and> 2.8 million deaths each year. Obesity is …

Obesity is recognized as a heterogeneous condition in which individuals with similar body
mass index may have distinct metabolic and cardiovascular risk profiles. Susceptibility to …

Although cardiologists have long treated patients with coronary artery disease (CAD) and
concomitant type 2 diabetes mellitus (T2DM), T2DM has traditionally been considered just a …

Background Long-term results from randomized, controlled trials that compare medical
therapy with surgical therapy in patients with type 2 diabetes are limited. Methods We …

Background Few long-term or controlled studies of bariatric surgery have been conducted to
date. We report the 12-year follow-up results of an observational, prospective study of Roux …

Objective Development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and the American College of …

This review focuses on the mechanisms underlying, and indications for, bariatric surgery in
the reduction of cardiovascular disease (CVD), as well as other expected benefits of this …

Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) are both
manifestations of end-organ damage of the metabolic syndrome. Through multiple …

Background: Bariatric surgery has been shown to significantly reduce cardiovascular risk
factors. However, whether surgery can reduce major adverse cardiovascular events …

Background In short-term randomized trials (duration, 1 to 2 years), bariatric surgery has
been associated with improvement in type 2 diabetes mellitus. Methods We assessed …